Chow L W, Gertsch P, Poon R T, Branicki F J
Department of Surgery, University of Hong Kong Medical Centre, Queen Mary Hospital, Hong Kong.
Br J Surg. 1998 Jan;85(1):121-4. doi: 10.1046/j.1365-2168.1998.00665.x.
Ageing populations are increasing in many countries and bleeding peptic ulcers in patients older than 60 years carry a greater risk of rebleeding and death. This study aimed to identify the risk factors for rebleeding and death in very elderly patients with peptic ulcer bleeding. The efficacy of treatment in preventing recurrent bleeding and death in this group of patients was also studied by means of prospective data collection and analysis.
Data relating to 1744 patients treated between September 1985 and January 1994 for peptic ulcer bleeding were collected prospectively and analysed. Patients were stratified by age to one of three groups: group 1 (less than 60 years, n = 833), group 2 (60-79 years, n = 706) and group 3 (80 or more years, n = 205).
Univariate and multivariate analyses of 21 factors possibly affecting either rebleeding or death identified age greater than 80 years as one of the factors significantly affecting rebleeding and death. In a comparison of groups 1, 2 and 3, the likelihood of rebleeding and death was significantly greater in group 3. Univariate and multivariate analyses for rebleeding and death were performed for each group. The severity of initial bleeding had a marked bearing on subsequent rebleeding rates for all three groups. In group 3, however, large ulcer size and impaired liver function were additional factors which correlated significantly with final outcome. No rebleeding or morbidity occurred when endoscopic treatment was performed early for patients in group 3 but there was a significantly greater risk of further recurrent haemorrhage and treatment-related morbidity when treatment was performed after the onset of rebleeding.
Patients aged 80 years or greater had the highest risk of rebleeding and death. For patients below 80 years of age, significant factors related to a fatal outcome included co-morbid illness, complications and the need for mechanical ventilation. For patients aged 80 years or older, the significant factors were ulcer size greater than 2 cm and admission with serum bilirubin level above 20 mmol/l. Endoscopic treatment for the very elderly was effective if carried out early.
许多国家的老年人口正在增加,60岁以上患者的消化性溃疡出血再出血和死亡风险更高。本研究旨在确定高龄消化性溃疡出血患者再出血和死亡的危险因素。通过前瞻性数据收集和分析,还研究了该组患者预防复发性出血和死亡的治疗效果。
前瞻性收集并分析了1985年9月至1994年1月间接受治疗的1744例消化性溃疡出血患者的数据。患者按年龄分为三组之一:第1组(小于60岁,n = 833),第2组(60 - 79岁,n = 706)和第3组(80岁及以上,n = 205)。
对可能影响再出血或死亡的21个因素进行单因素和多因素分析,确定年龄大于80岁是影响再出血和死亡的因素之一。在第1、2和3组的比较中,第3组再出血和死亡的可能性明显更大。对每组进行了再出血和死亡的单因素和多因素分析。初始出血的严重程度对所有三组随后的再出血率有显著影响。然而,在第3组中,溃疡面积大以及肝功能受损是与最终结局显著相关的其他因素。第3组患者早期进行内镜治疗时未发生再出血或并发症,但再出血发生后进行治疗时,进一步复发性出血和治疗相关并发症的风险显著更高。
80岁及以上患者再出血和死亡风险最高。对于80岁以下患者,与致命结局相关的重要因素包括合并症、并发症和机械通气需求。对于80岁及以上患者,重要因素是溃疡面积大于2 cm以及入院时血清胆红素水平高于20 mmol/l。高龄患者早期进行内镜治疗有效。